High activity of acid sphingomyelinase in major depression.
about
Identification of novel functional inhibitors of acid sphingomyelinaseQuantitative modeling of selective lysosomal targeting for drug designThe type 1 TNF receptor and its associated adapter protein, FAN, are required for TNFalpha-induced sickness behavior.Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogonsA central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depressionFunctional implications of novel human acid sphingomyelinase splice variantsAcid sphingomyelinase–ceramide system mediates effects of antidepressant drugsCharacterization of acid sphingomyelinase activity in human cerebrospinal fluidMechanisms of amine accumulation in, and egress from, lysosomes.Elevated plasma ceramides in depressionHarnessing the power of yeast to elucidate the role of sphingolipids in metabolic and signaling processes pertinent to psychiatric disorders.Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's diseaseRole of Acid Sphingomyelinase in the Regulation of Social Behavior and Memory.The Acid Sphingomyelinase Sequence Variant p.A487V Is Not Associated With Decreased Levels of Enzymatic Activity.Increased ceramide in brains with Alzheimer's and other neurodegenerative diseasesThe unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.Interferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab.Paradoxical antidepressant effects of alcohol are related to acid sphingomyelinase and its control of sphingolipid homeostasis.Ceramide 1-Phosphate Increases P-Glycoprotein Transport Activity at the Blood-Brain Barrier via Prostaglandin E2 Signaling.Acid sphingomyelinase in macrophage biology.Role of sphingomyelinases in neurological disorders.Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies.Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.Differential regulation of acid sphingomyelinase in macrophages stimulated with oxidized low-density lipoprotein (LDL) and oxidized LDL immune complexes: role in phagocytosis and cytokine release.A sphingolipid mechanism for behavioral extinction.Alleged Detrimental Mutations in the SMPD1 Gene in Patients with Niemann-Pick Disease.ALTERED BLOOD SPHINGOLIPIDOMICS AND ELEVATED PLASMA INFLAMMATORY CYTOKINES IN COMBAT VETERANS WITH POST-TRAUMATIC STRESS DISORDERSphingolipids in the lungs.Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.Low Vs. High Alcohol: Central Benefits Vs. Detriments.Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects
P2860
Q21003953-51C93B8E-12CD-4A02-B71B-83AAB6DD40E8Q24647940-D65BC053-605C-4082-8475-57DBB2245450Q24648146-86A5673C-BA55-4E5F-B811-8FB9D49ED554Q26852322-11A5DF64-F200-44A9-B57E-6120F5BAF5C9Q26866012-19E0B5F2-64DE-4668-9344-FC05C7322C18Q28482775-0C29C6FF-58D5-4907-ADB3-9F8998045166Q29042551-F134B46E-E3DB-4F97-828B-4727FDC4FB79Q34712835-A234140A-2A7D-4CD2-91D6-6EB77AE6736BQ34726610-EDAB5AB2-0A1F-4581-BE52-9AF92330E0EDQ35062581-32077B1A-CDB8-4BFB-B21F-533CCDFF8E12Q35149929-9D3D9A47-42AE-43A4-A885-8F0660A4914CQ35566575-594E4207-A848-4676-A17A-585BDAABAEF3Q36123988-6825841D-76E3-4E87-9615-2A65E9EB5084Q36590883-BACBCD02-C2B0-4F80-93D3-D479CF55A856Q36814487-9D447F2F-5C36-42FB-AB08-73A97128C92EQ36879383-DA773685-22DF-4FF2-AEC1-7D713E6003E7Q37389500-2D0F6BDA-7A41-4C18-87B6-39E38F462841Q37666339-00312BAF-B1B7-444B-B0A3-4C41C17A4CD5Q37718541-4B9821CD-946C-4242-BAC0-F8F8E170F963Q37870853-77059221-46DA-4E72-BE07-7DDAB8679A43Q38560939-D72555B6-172A-49FD-9ED1-28C70BE69229Q38607507-3E086A5A-8EB7-4D69-9807-28EEF652C5AEQ39320214-9889B837-4B5D-4559-9937-B9F4E313C4A0Q39413836-BB3C3C0B-EDF7-486D-B87B-7B8DBF01BAB7Q40084446-7872D41A-65AE-420F-8B76-5B213020A6E5Q41455009-C3F1A6AE-21E1-4AD4-9E0D-BD65BD68CE8BQ41853330-6A987718-186E-42C5-9CD8-3C221586BF05Q44965785-0DF4A718-5BD1-4D4D-91F8-6908056EA3ABQ46563505-312F4408-059F-4BE1-B32E-7DC8255435FFQ47663680-3ED11615-74B1-4F4A-8169-7829889DEAFDQ58772220-30C5E30E-385B-4D94-AE6D-38A8C36F1A02
P2860
High activity of acid sphingomyelinase in major depression.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
High activity of acid sphingomyelinase in major depression.
@ast
High activity of acid sphingomyelinase in major depression.
@en
High activity of acid sphingomyelinase in major depression.
@nl
type
label
High activity of acid sphingomyelinase in major depression.
@ast
High activity of acid sphingomyelinase in major depression.
@en
High activity of acid sphingomyelinase in major depression.
@nl
prefLabel
High activity of acid sphingomyelinase in major depression.
@ast
High activity of acid sphingomyelinase in major depression.
@en
High activity of acid sphingomyelinase in major depression.
@nl
P2093
P50
P1476
High activity of acid sphingomyelinase in major depression.
@en
P2093
P2888
P304
P356
10.1007/S00702-005-0374-5
P577
2005-11-01T00:00:00Z